Total Payments
$26,330
2024 Payments
$4,540
Companies
64
Transactions
1,602
Medicare Patients
4,038
Medicare Billing
$383,233
Payment Breakdown by Category
Food & Beverage$26,115 (99.2%)
Education$156.12 (0.6%)
Other$58.34 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,115 | 1,592 | 99.2% |
| Education | $156.12 | 6 | 0.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58.34 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $2,159 | 147 | $0 (2024) |
| UCB, Inc. | $2,007 | 117 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,973 | 123 | $0 (2024) |
| ABBVIE INC. | $1,921 | 128 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,797 | 115 | $0 (2024) |
| Amgen Inc. | $1,193 | 54 | $0 (2024) |
| Genentech USA, Inc. | $1,139 | 50 | $0 (2024) |
| SK Life Science, Inc. | $1,097 | 57 | $0 (2024) |
| Allergan, Inc. | $1,062 | 105 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $877.77 | 52 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,540 | 224 | ABBVIE INC. ($503.51) |
| 2023 | $4,554 | 231 | ACADIA Pharmaceuticals Inc ($500.26) |
| 2022 | $3,690 | 226 | ABBVIE INC. ($562.64) |
| 2021 | $3,562 | 233 | AbbVie Inc. ($440.34) |
| 2020 | $2,592 | 177 | UCB, Inc. ($321.20) |
| 2019 | $3,042 | 192 | Teva Pharmaceuticals USA, Inc. ($519.85) |
| 2018 | $2,735 | 185 | Novartis Pharmaceuticals Corporation ($381.22) |
| 2017 | $1,615 | 134 | Teva Pharmaceuticals USA, Inc. ($341.16) |
All Payment Transactions
1,602 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Neuroscience | ||||||
| 12/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: PAIN | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.97 | General |
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: PAIN | ||||||
| 11/15/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Immunology | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 834 | 932 | $300,668 | $88,626 |
| 2022 | 11 | 945 | 1,122 | $283,385 | $88,453 |
| 2021 | 12 | 1,018 | 1,173 | $312,714 | $96,324 |
| 2020 | 14 | 1,241 | 1,482 | $383,418 | $109,830 |
Total Patients
4,038
Total Services
4,709
Medicare Billing
$383,233
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 279 | 337 | $70,770 | $21,172 | 29.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 91 | 95 | $72,403 | $19,293 | 26.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 61 | 61 | $39,412 | $11,716 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $25,840 | $7,859 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 62 | $17,732 | $7,055 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 67 | $17,755 | $6,904 | 38.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $19,864 | $6,398 | 32.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 61 | $6,954 | $3,465 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 56 | $11,032 | $2,531 | 22.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 28 | 28 | $6,391 | $1,054 | 16.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 14 | 17 | $7,565 | $717.06 | 9.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 11 | 11 | $4,950 | $463.98 | 9.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 410 | 508 | $106,680 | $33,026 | 31.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 86 | 89 | $25,454 | $12,395 | 48.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 73 | 141 | $21,855 | $10,050 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $24,624 | $7,534 | 30.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 70 | 72 | $34,004 | $7,026 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 60 | $15,900 | $5,838 | 36.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 57 | 58 | $22,456 | $5,150 | 22.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $13,752 | $4,485 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 44 | $8,668 | $1,825 | 21.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 14 | 14 | $6,230 | $570.52 | 9.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 19 | 19 | $3,762 | $553.99 | 14.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 358 | 426 | $89,460 | $28,415 | 31.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 103 | 104 | $29,744 | $13,955 | 46.9% |
About Dr. Christopher Karcher, MD
Dr. Christopher Karcher, MD is a Neurology healthcare provider based in Ocean Springs, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194810408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Karcher, MD has received a total of $26,330 in payments from pharmaceutical and medical device companies, with $4,540 received in 2024. These payments were reported across 1,602 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($26,115).
As a Medicare-enrolled provider, Karcher has provided services to 4,038 Medicare beneficiaries, totaling 4,709 services with total Medicare billing of $383,233. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine, Neurology
- Location Ocean Springs, MS
- Active Since 10/03/2006
- Last Updated 10/08/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194810408
Products in Payments
- NUPLAZID (Drug) $2,159
- BOTOX (Biological) $1,191
- KESIMPTA (Drug) $1,046
- Briviact (Drug) $909.46
- UBRELVY (Drug) $788.50
- APTIOM (Drug) $784.23
- Aimovig (Biological) $777.85
- Vimpat (Drug) $700.55
- AJOVY (Drug) $659.63
- VYEPTI (Biological) $630.72
- ULTOMIRIS (Biological) $607.94
- OCREVUS (Biological) $570.26
- UPLIZNA (Drug) $552.65
- TYSABRI (Biological) $526.44
- NURTEC ODT (Drug) $514.76
- QULIPTA (Drug) $491.11
- GILENYA (Drug) $435.19
- ZEPOSIA (Drug) $407.79
- UPLIZNA (Biological) $381.86
- INSPIRE (Device) $357.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.